Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06185881
Other study ID # CEBD 5/2022
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date December 28, 2023

Study information

Verified date February 2024
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research proposal is introduced to clinically test short fiber reinforced glass ionomer material from GC Europe due to gap of knowledge present in this area. It is characterized by higher flexural strength compared to resin modified glass ionomer (RMGIC). Additionally, the short fibers provided effective toughening of the RMGIC matrix by a fiber bridging mechanism.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date December 28, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 38 Years
Eligibility Inclusion Criteria: - Patients with untreated cervical carious lesions - Patients with normal occlusion - Vital teeth with carious cervical lesion with asymptomatic vital pulp. - Teeth with no or minimum mobility. - Teeth with normal occlusion. - Teeth with surrounding healthy gingiva and supporting-structures. Exclusion Criteria: - Patients who are unable to return for recall appointments - Presence of abnormal oral, medical or mental conditions. - Patients with severe medical diseases. - Patients with xerostomia - Patients with parafunctional habits. - Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis. - Severe periodontal problems. - Non carious cervical lesions.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
restoration of cervical carious teeth
restoration of carious cervical lesions by glass ionomer

Locations

Country Name City State
Egypt Faculty of Dentistry Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Marginal integrity score Modified USPHS criteria with Alpha, Bravo and Charlie scores (Categorical) [Time Frame: Baseline, 6 months, 12 months]
Secondary Change in Marginal discoloration, Color match, Gross fracture scores Modified USPHS criteria with Alpha, Bravo and Charlie scores (Categorical) [Time Frame: Baseline, 6 months, 12 months]
Secondary Change in Secondary caries scores Modified USPHS criteria with Alpha and Charlie scores (Categorical) [Time Frame: Baseline, 6 months, 12 months]
Secondary Change in Post operative Hypersensitivity Modified USPHS criteria with Alpha and Charlie scores (Categorical) [Time Frame: Baseline, 7 days, 6 months]
See also
  Status Clinical Trial Phase
Recruiting NCT03501784 - Nobio Antimicrobial Particles Effect in a Split Mouth Model N/A
Recruiting NCT06394440 - Clinical Evaluation of Self-Adhesive Bulk-Fill Composite Versus Conventional Nano-hybrid Composite in Cervical Cavities N/A
Recruiting NCT05624008 - Clinical Performance of Bioceramic vs High Viscosity GIC for Cervical Restorations of Geriatric Patients N/A